Aline Martins dos Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aline Martins dos Santos has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Marlus Chorilli
São Paulo State University (UNESP)
8 shared publications Andréia Bagliotti Meneguin
São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara, SP 14800-903, Brazil
3 shared publications- Bruno Fonseca-Santos
Interactive Processes of Organs and Systems Postgraduate Program, Health Sciences Institute, Federal University of Bahia (UFBA), Salvador, Bahia, Brazil; Pharmacy Postgraduate Program, School of Pharmacy, Federal University of Bahia (UFBA), Salvador, Bahia, Brazil
3 shared publications - Maria Palmira Daflon Gremião
School of Pharmaceutical Sciences, São Paulo State University, Rodovia Araraquara—Jaú Km 1, Araraquara 14800-903, SP, Brazil
3 shared publications - Andréia Bagliotti Meneguin
Universidade Estadual de São Paulo, Brazil
2 shared publications - Beatriz Stringhetti Ferreira Cury
School of Pharmaceutical Sciences, São Paulo State University (UNESP)
2 shared publications
Latest Publications
- Open Access
- 4 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2254
Rhamnolipids and Essential Oils: A New Approach to Managing Bacteria Associated with Skin Diseases
The rise of antimicrobial-resistant pathogens has increased interest in biologically derived compounds for treating dermal infections. This study evaluates the effect of rhamnolipid, a biosurfactant produced by Pseudomonas aeruginosa, in combination with essential oils of oregano (Origanum vulgare), tea tree (Melaleuca alternifolia), and cinnamon (Cinnamomum cassia) against Cutibacterium acnes and Staphylococcus aureus, with or without incorporation into a sodium alginate-based film. Minimum bactericidal concentrations (MBC), biofilm inhibition development, and time-kill assays were used to assess antimicrobial activity. Results indicate MBCs of 800 mg/L for rhamnolipid, 0.05% for oregano, 0.2% for tea tree oil, and 0.5% for cinnamon against C. acnes. For S. aureus, the MBCs are 2500 mg/L, 0.07%, 0.3%, and 0.5%, respectively. When combined the rhamnolipids and the essential oils, the MBC for C. acnes were reduced to 500 mg/L of rhamnolipid and essential oils of oregano, tea tree and cinnamon were reduced to 0.03%, 0.1% and 0.3%, respectively, and for S. aureus were reduced to 1500 mg/L of rhamnolipid and essential oils of oregano, tea tree and cinnamon were reduced to 0.05%, 01% and 0.3%, respectively. A sodium alginate-based polymer film was formulated with rhamnolipid, maintaining antimicrobial efficacy and water-retention capacity but with reduced mechanical strength. These findings suggest a promising topical application for treating dermal infections.
- 4 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2254
Open AccessRhamnolipids and Essential Oils: A New Approach to Managing Bacteria Associated with Skin Diseases
The rise of antimicrobial-resistant pathogens has increased interest in biologically derived compounds for treating dermal infections. This study evaluates the effect of rhamnolipid, a biosurfactant produced by Pseudomonas aeruginosa, in combination with essential oils of oregano (Origanum vulgare), tea tree (Melaleuca alternifolia), and cinnamon (Cinnamomum cassia) against Cutibacterium acnes and Staphylococcus aureus, with or without incorporation into a sodium alginate-based film. Minimum bactericidal concentrations (MBC), biofilm inhibition development, and time-kill assays were used to assess antimicrobial activity. Results indicate MBCs of 800 mg/L for rhamnolipid, 0.05% for oregano, 0.2% for tea tree oil, and 0.5% for cinnamon against C. acnes. For S. aureus, the MBCs are 2500 mg/L, 0.07%, 0.3%, and 0.5%, respectively. When combined the rhamnolipids and the essential oils, the MBC for C. acnes were reduced to 500 mg/L of rhamnolipid and essential oils of oregano, tea tree and cinnamon were reduced to 0.03%, 0.1% and 0.3%, respectively, and for S. aureus were reduced to 1500 mg/L of rhamnolipid and essential oils of oregano, tea tree and cinnamon were reduced to 0.05%, 01% and 0.3%, respectively. A sodium alginate-based polymer film was formulated with rhamnolipid, maintaining antimicrobial efficacy and water-retention capacity but with reduced mechanical strength. These findings suggest a promising topical application for treating dermal infections.
- Top Cited PapersOpen Access
- 19 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (14) , e03964
Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design
Tuberculosis (TB), caused by Mycobacterium tuberculosis ( Mtb ), remains a major global health concern, particularly due to the emergence of multidrug‐resistant and extensively drug‐resistant strains. The persistence and propagation of TB are favored by the pathogen's sophisticated virulence mechanisms, its ability to evade immune responses, and the formation of latent infections within granulomas. Current therapeutic regimens are limited by long treatment durations, drug resistance, and significant socioeconomic burdens. Antimicrobial peptides (AMPs) have emerged as promising alternatives because of their broad‐spectrum activity and reduced likelihood of resistance development. Nevertheless, their clinical application is hindered by rapid proteolytic degradation, low specificity and limited bioavailability. Recent advances in nanotechnology have facilitated the encapsulation and targeted delivery of AMPs, improving their therapeutic potential against TB. Furthermore, the integration of computational approaches—such as molecular docking and molecular dynamics (MD) simulations—has enabled the rational design and optimization of AMPs, expediting the discovery of novel anti‐TB agents. This review summarizes the pathogenesis and resistance mechanisms of Mtb , highlights the current landscape and limitations of AMP‐based therapies, and discusses the role of nanotechnology and in silico tools in the development of new treatment strategies for TB.
- 19 January 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (14) , e03964
Top Cited PapersOpen AccessRedefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design
Tuberculosis (TB), caused by Mycobacterium tuberculosis ( Mtb ), remains a major global health concern, particularly due to the emergence of multidrug‐resistant and extensively drug‐resistant strains. The persistence and propagation of TB are favored by the pathogen's sophisticated virulence mechanisms, its ability to evade immune responses, and the formation of latent infections within granulomas. Current therapeutic regimens are limited by long treatment durations, drug resistance, and significant socioeconomic burdens. Antimicrobial peptides (AMPs) have emerged as promising alternatives because of their broad‐spectrum activity and reduced likelihood of resistance development. Nevertheless, their clinical application is hindered by rapid proteolytic degradation, low specificity and limited bioavailability. Recent advances in nanotechnology have facilitated the encapsulation and targeted delivery of AMPs, improving their therapeutic potential against TB. Furthermore, the integration of computational approaches—such as molecular docking and molecular dynamics (MD) simulations—has enabled the rational design and optimization of AMPs, expediting the discovery of novel anti‐TB agents. This review summarizes the pathogenesis and resistance mechanisms of Mtb , highlights the current landscape and limitations of AMP‐based therapies, and discusses the role of nanotechnology and in silico tools in the development of new treatment strategies for TB.
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 28 (18) , 1501-1512
An Updated Review on Properties, Nanodelivery Systems, and Analytical Methods for the Determination of 5-Fluorouracil in Pharmaceutical and Biological Samples
5-Fluorouracil (5-FU) is an antimetabolite drug used for over 70 years as first-line chemotherapy to treat various types of cancer, such as head, neck, breast, and colorectal cancer. 5-FU acts mainly by inhibiting thymidylate synthase, thereby interfering with deoxyribonucleic acid (DNA) replication or by 5-FU incorporating into DNA, causing damage to the sequence of nucleotides. Being analogous to uracil, 5-FU enters cells using the same transport mechanism, where a is converted into active metabolites such as fluorouridine triphosphate (FUTP), fluorodeoxyuridine monophosphate (FdUMP), and fluorodeoxyuridine triphosphate (FdUTP). Currently, there are several nano delivery systems being developed and evaluated at the preclinical level to overcome existing limitations to 5-FU chemotherapy, including liposomes, polymeric nanoparticles, polymeric micelles, nanoemulsions, mesoporous silica nanoparticles, and solid lipid nanoparticles. Therefore, it is essential to choose and develop suitable analytical methods for the quantification of 5-FU and its metabolites (5- fluorouridine and 5-fluoro-2-deoxyuridine) in pharmaceutical and biological samples. Among the analytical techniques, chromatographic methods are commonly the most used for the quantification of 5-FU from different matrices. However, other analytical methods have also been developed for the determination of 5-FU, such as electrochemical methods, a sensitive, selective, and precise technique, in addition to having a reduced cost. Here, we first review the physicochemical properties, mechanism of action, and advances in 5-FU nanodelivery systems. Next, we summarize the current progress of other chromatographic methods described to determine 5- FU. Lastly, we discuss the advantages of electrochemical methods for the identification and quantification of 5- FU and its metabolites in pharmaceutical and biological samples.
- 1 May 2022
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 28 (18) , 1501-1512
An Updated Review on Properties, Nanodelivery Systems, and Analytical Methods for the Determination of 5-Fluorouracil in Pharmaceutical and Biological Samples
5-Fluorouracil (5-FU) is an antimetabolite drug used for over 70 years as first-line chemotherapy to treat various types of cancer, such as head, neck, breast, and colorectal cancer. 5-FU acts mainly by inhibiting thymidylate synthase, thereby interfering with deoxyribonucleic acid (DNA) replication or by 5-FU incorporating into DNA, causing damage to the sequence of nucleotides. Being analogous to uracil, 5-FU enters cells using the same transport mechanism, where a is converted into active metabolites such as fluorouridine triphosphate (FUTP), fluorodeoxyuridine monophosphate (FdUMP), and fluorodeoxyuridine triphosphate (FdUTP). Currently, there are several nano delivery systems being developed and evaluated at the preclinical level to overcome existing limitations to 5-FU chemotherapy, including liposomes, polymeric nanoparticles, polymeric micelles, nanoemulsions, mesoporous silica nanoparticles, and solid lipid nanoparticles. Therefore, it is essential to choose and develop suitable analytical methods for the quantification of 5-FU and its metabolites (5- fluorouridine and 5-fluoro-2-deoxyuridine) in pharmaceutical and biological samples. Among the analytical techniques, chromatographic methods are commonly the most used for the quantification of 5-FU from different matrices. However, other analytical methods have also been developed for the determination of 5-FU, such as electrochemical methods, a sensitive, selective, and precise technique, in addition to having a reduced cost. Here, we first review the physicochemical properties, mechanism of action, and advances in 5-FU nanodelivery systems. Next, we summarize the current progress of other chromatographic methods described to determine 5- FU. Lastly, we discuss the advantages of electrochemical methods for the identification and quantification of 5- FU and its metabolites in pharmaceutical and biological samples.
- 1 November 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 590, 119867
Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections
- 1 November 2020
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 590, 119867
Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections
- 1 June 2018
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 127, 112-119
Supramolecular cyclodextrin-based metal-organic frameworks as efficient carrier for anti-inflammatory drugs
- 1 June 2018
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 127, 112-119
Supramolecular cyclodextrin-based metal-organic frameworks as efficient carrier for anti-inflammatory drugs
- 1 January 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 179, 126-134
Effect of in situ modification of bacterial cellulose with carboxymethylcellulose on its nano/microstructure and methotrexate release properties
- 1 January 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 179, 126-134
Effect of in situ modification of bacterial cellulose with carboxymethylcellulose on its nano/microstructure and methotrexate release properties
- Open Access
- 1 September 2017
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 12, 6883-6893
Trans-resveratrol-loaded nonionic lamellar liquid-crystalline systems: structural, rheological, mechanical, textural, and bioadhesive characterization and evaluation of in vivo anti-inflammatory activity
Resveratrol (Res) is a common phytoalexin present in a few edible materials, such as grape skin, peanuts, and red wine. Evidence has shown the beneficial effects of Res on human health, which may be attributed to its anti-inflammatory activity. However, the poor aqueous solubility of Res limits its therapeutic effectiveness. Therefore, the use of nanostructured delivery systems for Res, such as liquid-crystalline systems, could be beneficial. In this study, we aimed to develop, characterize, and determine the in vivo effectiveness of Res-loaded liquid-crystalline systems. Systems containing copaiba balsam oil, polyethylene glycol-40 hydrogenated castor oil, and water were designed. Results of polarized light microscopy, small-angle X-ray scattering, texture-profile analysis, and flow-rheology analysis showed that the Res-loaded liquid-crystalline system had a lamellar structure, textural and mechanical (hardness, compressibility, and adhesiveness) properties, and behaved as a non-Newtonian fluid, showing pseudoplastic behavior upon skin application. Furthermore, all liquid-crystalline systems presented bioadhesive properties that may have assisted in maintaining the anti-inflammatory activity of Res, since the topical application of the Res-loaded lamellar mesophase liquid crystals resulted in edema inhibition in a carrageenan-induced paw-inflammation mouse model. Therefore, Res-loaded lamellar mesophases represent a promising new therapeutic approach for inhibition of skin inflammation.
- 1 September 2017
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 12, 6883-6893
Open AccessTrans-resveratrol-loaded nonionic lamellar liquid-crystalline systems: structural, rheological, mechanical, textural, and bioadhesive characterization and evaluation of in vivo anti-inflammatory activity
Resveratrol (Res) is a common phytoalexin present in a few edible materials, such as grape skin, peanuts, and red wine. Evidence has shown the beneficial effects of Res on human health, which may be attributed to its anti-inflammatory activity. However, the poor aqueous solubility of Res limits its therapeutic effectiveness. Therefore, the use of nanostructured delivery systems for Res, such as liquid-crystalline systems, could be beneficial. In this study, we aimed to develop, characterize, and determine the in vivo effectiveness of Res-loaded liquid-crystalline systems. Systems containing copaiba balsam oil, polyethylene glycol-40 hydrogenated castor oil, and water were designed. Results of polarized light microscopy, small-angle X-ray scattering, texture-profile analysis, and flow-rheology analysis showed that the Res-loaded liquid-crystalline system had a lamellar structure, textural and mechanical (hardness, compressibility, and adhesiveness) properties, and behaved as a non-Newtonian fluid, showing pseudoplastic behavior upon skin application. Furthermore, all liquid-crystalline systems presented bioadhesive properties that may have assisted in maintaining the anti-inflammatory activity of Res, since the topical application of the Res-loaded lamellar mesophase liquid crystals resulted in edema inhibition in a carrageenan-induced paw-inflammation mouse model. Therefore, Res-loaded lamellar mesophases represent a promising new therapeutic approach for inhibition of skin inflammation.